Rezdiffra (Resmetirom): A New Hope for Nonalcoholic Steatohepatitis Treatment
Nonalcoholic Steatohepatitis (NASH) is a complex liver disorder characterized by the accumulation of fat in liver cells, accompanied by inflammation and damage to liver tissue. It is considered a progressive form of nonalcoholic fatty liver disease (NAFLD) and is increasingly recognized as a serious health concern. NASH is associated with various risk factors, predominantly obesity,…